生検装置市場 – 2030年までの世界予測

Report Overview

The global biopsy device market is projected to reach USD 11.01 billion by 2030 from USD 7.27 billion in 2024, at a CAGR of 7.2% during the forecast period.

世界の生検装置市場は、予測期間中に年平均成長率 7.2% で成長し、2024 年の 72 億 7,000 万米ドルから 2030 年には 110 億 1,000 万米ドルに達すると予測されています。

One of the biggest drivers is the growing incidence of cancer, especially breast, lung, and prostate cancers, which need precise and early diagnostic tests. The World Health Organization states that cancer cases are likely to increase substantially by 2030. Therefore, there would be an increasing demand for biopsy devices. Also, the growing demand for less invasive procedures is driving market growth further. The newer biopsy methods like vacuum-assisted and liquid biopsies are more accurate, have lower recovery times, and cause lower patient discomfort Furthermore, advances in technology, such as robotic-assisted biopsy machines, AI-based diagnostic systems, and image-guided biopsy procedures, improve accuracy and efficiency, driving market growth further. Moreover, rising government programs for cancer screening, combined with rising healthcare spending, especially in developing nations, drive the market forward. Nonetheless, the high prices of sophisticated biopsy devices and strict regulatory environments can serve as constraints.

最大の推進力の1つは、正確で早期の診断検査を必要とするがん、特に乳がん、肺がん、前立腺がんの発生率の増加です。世界保健機関は、がん症例は2030年までに大幅に増加する可能性があると述べています。したがって、生検装置の需要が増加するでしょう。また、低侵襲性処置の需要の高まりも、市場の成長をさらに促進しています。真空支援生検や液体生検などの新しい生検方法は、より正確で、回復時間が短く、患者の不快感が少ないです。さらに、ロボット支援生検機器、AIベースの診断システム、画像誘導生検手順などの技術の進歩により、精度と効率が向上し、市場の成長がさらに促進されています。さらに、がんスクリーニングのための政府プログラムの増加と、特に発展途上国での医療費の増加が市場を前進させています。とはいえ、高度な生検装置の高価格と厳格な規制環境が制約となる可能性があります。

“The needle-based biopsy instrument segment to grow the fastest during the forecast period.”

Based on the product, the biopsy device market is divided into Needle-based biopsy instrument, Visualization device, Brush biopsy instrument, Biopsy accessory and Robotic biopsy device. Among these, in 2023, Needle-based biopsy instrument segment account for the highest growing segment  of 7.8% in biopsy device market. This is due to rising preference for the  utilization of minimally invasive diagnostic interventions. The Needle biopsy devices such as core needle biopsy (CNB), fine needle aspiration biopsy (FNAB), and vacuum-assisted biopsy (VAB) devices provide a less painful and less invasive alternative to surgical biopsies. This lowers patient pain, recovery time, and procedural expenses. Moreover, the growing focus on early disease detection and precision medicine has also driven demand for needle biopsies, as they yield very accurate tissue samples with few complications. Further, the increasing trend towards ambulatory and outpatient facilities for biopsies has also increased the market, as needle biopsies are quick and require little infrastructure. However, the risks of bleeding, infection, and sampling errors pose challenges to the growth of this market.

“The gastroenterology segment accounts for the  second largest market share in biopsy device market.”

Based on application, the biopsy device market is segmented into oncology, Gastroenterology, Bone & Bone marrow biopsy and other applications. The gastroenterology segment accounts for the second largest market share in biopsy device market. This can be attributed to the growing cased of gastrointestinal (GI) diseases  and technological advancements in endoscopic biopsy methods. Moreover, the GI disorders such as Colorectal cancer, gastric cancer, inflammatory bowel disease (IBD), celiac disease, and gastrointestinal infections need biopsy procedures for proper diagnosis. Further, the increasing incidence of colorectal cancer, one of the most recurrently diagnosed cancers globally, makes a major contribution to the need for GI biopsy devices. Furthermore, the growing use of image-guided biopsy methods, namely endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) and fine-needle biopsy (EUS-FNB), improves diagnostic accuracy in deep-seated GI tumors, contributing to market growth. Moreover, rise in geriatric population suffering from GI disorders and advancements in healthcare infrastructure on a worldwide level favour market growth.

“Asia Pacific accounted for the  fastest growing of the biopsy device market by region.”

The global biopsy device market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Asia Pacific is the  fastest growing regional market for the biopsy device and is estimated to grow at the highest CAGR during the forecast period. The increasing incidence of cancer, coupled by demographic changes and lifestyle factors, has increased the need for early diagnosis, driving the use of biopsy procedures. Development of healthcare infrastructure, especially in nations such as China, India, and Japan, has increased access to sophisticated diagnostic technologies. Further, government initiatives and rising healthcare expenditures have also aided cancer screening programs, stimulating market growth. Moreover, the growing medical tourism industry in the region, specifically  in countries with low-cost yet high-quality biopsy services, has also increased the growth in demand.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1–45%, Tier 2–30%, and Tier 3– 25%
• By Designation: C-level–35%, Director-level–25% and Others–40%
• By Region: North America–40%, Europe–20%, Asia Pacific–25%, Latin America- 10%, and Middle east and Africa-5%

Note 1: Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.

Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.

Note 3: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

The major players operating in the biopsy device market are BD (US), Devicor medical products, Inc (US), Medtronic (Ireland), Cardinal Health (US), B.Braun SE ( Germany),  Hologic,Inc (US), Olympus Corporation (Japan), Boston Scientific Corporation (US), FUJIFILM Corporation (Japan), Stryker (US), Teleflex Incorporated (US), CONMED Corporation (US), Merit Medical Systems (US),  Johnson & Johnson Services,Inc. (US), Cook Group (US), MicroPort Scientific Corporation (China),  Argon Medical Devices (US), INRAD, Inc (US), Summit Medical LLC (US), TransMed7, LLC (US), Dr. Japan Co., Ltd. (Japan), IZI Medical Products (US), Planmed Oy (Finland), Advin Health Care (India), Trivitron Healthcare (India).

Research Coverage

This report studies the biopsy device market based on product, type, technology, application end user and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:

• Analysis of Key divers (Rising prevalence of cancer), restraints (Increasing product recalls), Challenge (Technological advancements), opportunity (Underdeveloped healthcare infrastructure in emerging economies)
• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the bbiopsy device market
• Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the biopsy device market
• Market Development: Comprehensive information on lucrative emerging regions
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the biopsy devices market
• Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

Table of Contents

1               INTRODUCTION              42

1.1           STUDY OBJECTIVES       42

1.2           MARKET DEFINITION   42

1.3           STUDY SCOPE   43

1.3.1        MARKET SEGMENTATION & GEOGRAPHIC SPREAD                 43

1.3.2        INCLUSIONS & EXCLUSIONS       44

1.4           YEARS CONSIDERED      45

1.5           CURRENCY CONSIDERED            45

1.6           STAKEHOLDERS               46

1.7           SUMMARY OF CHANGES               46

2               RESEARCH METHODOLOGY       47

2.1           RESEARCH DATA              47

2.1.1        SECONDARY DATA          48

2.1.1.1    Key data from secondary sources       49

2.1.2        PRIMARY DATA 49

2.1.2.1    Key data from primary sources           51

2.1.2.2    Key industry insights           51

2.2           MARKET SIZE ESTIMATION         52

2.3           ASSESSMENT OF MARKET SEGMENTS    56

2.4           ASSESSMENT OF GEOGRAPHIC SEGMENTS         56

2.5           MARKET BREAKDOWN & DATA TRIANGULATION                 56

2.6           RESEARCH ASSUMPTIONS           57

2.7           RESEARCH LIMITATIONS             58

2.7.1        METHODOLOGY-RELATED LIMITATIONS           58

2.7.2        SCOPE-RELATED LIMITATIONS                 58

2.8           RISK ASSESSMENT           58

3               EXECUTIVE SUMMARY  59

4               PREMIUM INSIGHTS       64

4.1           OPPORTUNITIES FOR PLAYERS IN BIOPSY DEVICES MARKET               64

4.2           NORTH AMERICA: BIOPSY DEVICES MARKET, BY END USER     65

4.3           BIOPSY DEVICES MARKET: GEOGRAPHIC SNAPSHOT                 66

4.4           BIOPSY DEVICES MARKET: GEOGRAPHIC MIX    67

4.5           BIOPSY DEVICES MARKET: DEVELOPING VS. DEVELOPED MARKETS,

2024 VS. 2030 (USD MILLION)      67

5               MARKET OVERVIEW       68

5.1           INTRODUCTION              68

5.2           MARKET DYNAMICS       68

5.2.1        DRIVERS               69

5.2.1.1    Rising prevalence of cancer 69

5.2.1.2    Increasing preference for minimally invasive surgeries  69

5.2.1.3    Initiatives undertaken by governments and global health organizations         69

5.2.1.4    Increased number of hospitals and diagnostic centers   70

5.2.1.5    Improved reimbursement policies     70

5.2.2        RESTRAINTS      71

5.2.2.1    Increasing product recalls   71

5.2.2.2    High risk of infections          71

5.2.3        OPPORTUNITIES              71

5.2.3.1    Technological advancements              71

5.2.3.2    Growing investments in emerging economies 72

5.2.4        CHALLENGES    72

5.2.4.1    Underdeveloped healthcare infrastructure in emerging economies              72

5.3           INDUSTRY TRENDS         72

5.3.1        MINIMALLY INVASIVE PROCEDURES      73

5.3.2        ROBOTIC-ASSISTED BIOPSY DEVICES    73

5.3.3        LIQUID BIOPSY TECHNOLOGY 74

5.4           TECHNOLOGY ANALYSIS             74

5.4.1        KEY TECHNOLOGIES     74

5.4.1.1    Robotic-assisted biopsy devices         74

5.4.1.2    Optical biopsy technologies                75

5.4.1.3    Minimally invasive biopsy devices     75

5.4.2        COMPLEMENTARY TECHNOLOGIES       75

5.4.2.1    Imaging technologies           75

5.4.2.2    Tissue analysis technologies                76

5.4.2.3    Artificial intelligence            76

5.4.3        ADJACENT TECHNOLOGIES       77

5.4.3.1    Digital pathology and AI integration 77

5.4.3.2    Precision medicine tools     77

5.4.3.3    Advanced needle and probe technologies         77

5.5           PORTER’S FIVE FORCES ANALYSIS           78

5.5.1        THREAT FROM NEW ENTRANTS                78

5.5.2        BARGAINING POWER OF SUPPLIERS       78

5.5.3        BARGAINING POWER OF BUYERS             79

5.5.4        THREAT FROM SUBSTITUTES   79

5.5.5        INTENSITY OF COMPETITIVE RIVALRY 79

5.6           REGULATORY LANDSCAPE         80

5.6.1        REGULATIONS, BY REGION         80

5.6.1.1    North America      80

5.6.1.1.1 US           80

5.6.1.1.2 Canada   80

5.6.1.2    Europe   81

5.6.1.3    Asia Pacific            81

5.6.1.4    Latin America       81

5.6.1.5    Middle East & Africa            82

5.6.2        REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             82

5.7           PATENT ANALYSIS          85

5.7.1        PATENT PUBLICATION TRENDS IN BIOPSY DEVICES MARKET               85

5.7.2        INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS            85

5.8           TRADE ANALYSIS             88

5.9           PRICING ANALYSIS          89

5.9.1        AVERAGE SELLING PRICE OF KEY PLAYERS, BY KEY PRODUCT           89

5.9.2        AVERAGE SELLING PRICE TREND OF BIOPSY DEVICES, BY REGION         90

5.10         KEY CONFERENCES & EVENTS   90

5.11         KEY STAKEHOLDERS & BUYING CRITERIA            91

5.11.1      KEY STAKEHOLDERS IN BUYING PROCESS           91

5.11.2      BUYING CRITERIA           92

5.12         BIOPSY DEVICES MARKET: UNMET NEEDS/EXPECTATIONS OF END USERS 93

5.13         ECOSYSTEM ANALYSIS  94

5.14         CASE STUDY ANALYSIS 95

5.14.1      CASE STUDY 1: DEVICELAB COLLABORATED WITH CLINICAL EXPERTS TO IDENTIFY LIMITATIONS OF EXISTING BREAST BIOPSY PROCEDURES  95

5.14.2      CASE STUDY 2: RESEARCHERS AT UNIVERSITY OF TWENTE DESIGNED ROBOTIC SETUP AND SOFTWARE ARCHITECTURE TO ASSIST RADIOLOGISTS IN TARGETING MRI-DETECTED SUSPICIOUS TUMORS            96

5.14.3      CASE STUDY 3: RESEARCH TEAM DESIGNED FLEXIBLE ROBOTIC SYSTEM FOR BIOPSY SAMPLING APPLIED TO HUMAN CORPSES PLACED INSIDE PROTECTIVE BODY BAGS       96

5.15         SUPPLY CHAIN ANALYSIS             97

5.16         ADJACENT MARKET ANALYSIS  99

5.16.1      BREAST BIOPSY DEVICES MARKET           99

5.17         TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS            100

5.18         INVESTMENT & FUNDING SCENARIO     101

5.19         IMPACT OF AI ON BIOPSY DEVICES MARKET      101

6               BIOPSY DEVICES MARKET, BY PRODUCT              103

6.1           INTRODUCTION              104

6.2           NEEDLE-BASED BIOPSY INSTRUMENT  105

6.2.1        CORE NEEDLE BIOPSY  107

6.2.1.1    Core needle biopsy device  110

6.2.1.1.1 Semi-automatic     114

6.2.1.1.1.1              Need for balance of user control and automated functionality in procedures to drive market     114

6.2.1.1.2 Automatic              116

6.2.1.1.2.1              Demand for efficiency and accuracy in biopsy procedures to boost growth 116

6.2.1.2    Core needle biopsy needle  118

6.2.1.2.1 Disposable             121

6.2.1.2.1.1              Need for infection control and safety concerns to boost growth    121

6.2.1.2.2 Reusable 123

6.2.1.2.2.1              Cost-effectiveness of reusable core biopsy needles to drive market          123

6.2.2        FINE NEEDLE ASPIRATION BIOPSY          125

6.2.2.1    Innovations in needle design, including thinner profiles and improved tip configurations, to drive market   125

6.2.3        VACUUM-ASSISTED BIOPSY        128

6.2.3.1    Increasing need for early and accurate cancer detection to drive market    128

6.3           VISUALIZATION DEVICE/SYSTEM            131

6.3.1        RISING PREVALENCE OF CANCER AND OTHER CHRONIC CONDITIONS

TO DRIVE DEMAND FOR VISUALIZATION DEVICE           131

6.4           BRUSH BIOPSY INSTRUMENT    133

6.4.1        PREFERENCE FOR MINIMALLY INVASIVE BIOPSY PROCEDURES

TO BOOST MARKET        133

6.5           BIOPSY ACCESSORY        135

6.5.1        BIOPSY FORECEP             138

6.5.1.1    General biopsy forcep          141

6.5.1.1.1 Demand for minimally invasive procedures and precise diagnostics to surge growth                 141

6.5.1.2    Hot biopsy forecep                143

6.5.1.2.1 Unique ability of hot biopsy forecep to cut and coagulate tissue to support growth 143

6.5.2        TISSUE MARKER                145

6.5.2.1    Rising cases of breast cancer to boost market growth     145

6.5.3        LOCALIZATION WIRE    147

6.5.3.1    Ability of localization wire to detect precise target locations to drive growth          147

6.5.4        OTHER ACCESSORIES    150

6.6           ROBOTIC BIOPSY DEVICE            151

6.6.1        RAPID DEVELOPMENT OF ROBOTIC BIOPSY DEVICES TO BOOST GROWTH      151

7               BIOPSY DEVICES MARKET, BY TECHNOLOGY     154

7.1           INTRODUCTION              155

7.2           ULTRASOUND-GUIDED BIOPSY                155

7.2.1        ULTRASOUND GUIDANCE ENHANCES SAFETY, MINIMIZES COMPLICATIONS, AND IMPROVES DIAGNOSTIC ACCURACY          155

7.3           STEREOTACTIC-GUIDED BIOPSY             157

7.3.1        NEED FOR EFFICIENT AND ACCURATE BIOPSY PROCEDURES

TO SUPPORT MARKET GROWTH              157

7.4           OTHER TECHNOLOGIES               159

8               BIOPSY DEVICES MARKET, BY APPLICATION      162

8.1           INTRODUCTION              163

8.2           ONCOLOGY        164

8.2.1        BREAST CANCER              166

8.2.1.1    Increasing demand for early and accurate diagnosis to boost growth    166

8.2.2        SOFT TISSUE CANCER   168

8.2.2.1    Advancements in diagnostics and growing emphasis on cancer therapeutics to drive market               168

8.3           GASTROENTEROLOGY 170

8.3.1        RISING INCIDENCE OF GASTROINTESTINAL DISEASES TO DRIVE MARKET         170

8.4           BONE & BONE MARROW BIOPSY               172

8.4.1        RISING EMPHASIS ON BONE MARROW BIOPSIES

TO SUPPORT MARKET GROWTH              172

8.5           OTHER APPLICATIONS 175

9               BIOPSY DEVICES MARKET, BY END USER              177

9.1           INTRODUCTION              178

9.2           HOSPITALS & BREAST CARE CENTERS   179

9.2.1        DEMAND FOR STATE-OF-THE-ART BIOPSY FACILITIES TO DRIVE MARKET         179

9.3           DIAGNOSTIC IMAGING CENTERS             182

9.3.1        INCREASING NUMBER OF PRIVATE IMAGING CENTERS

TO SUPPORT MARKET GROWTH              182

9.4           AMBULATORY SURGICAL CENTERS        184

9.4.1        GROWING FOCUS ON AMBULATORY CARE TO DRIVE MARKET               184

9.5           OTHER END USERS         187

10            BIOPSY DEVICES MARKET, BY REGION  189

10.1         INTRODUCTION              190

10.2         NORTH AMERICA             193

10.2.1      MACROECONOMIC OUTLOOK  193

10.2.2      US           203

10.2.2.1  Growth in elderly population to drive market  203

10.2.3      CANADA               212

10.2.3.1  Rising government investments to drive growth              212

10.3         EUROPE               220

10.3.1      MACROECONOMIC OUTLOOK  220

10.3.2      GERMANY           229

10.3.2.1  Increasing prevalence of chronic diseases to propel market                 229

10.3.3      UK          237

10.3.3.1  Initiatives by government to support market growth      237

10.3.4      FRANCE                245

10.3.4.1  Rising number of diagnostic imaging centers to drive market                 245

10.3.5      ITALY    254

10.3.5.1  Availability of reimbursement coverage to support market growth                 254

10.3.6      SPAIN    262

10.3.6.1  Increasing focus on cancer research to propel market    262

10.3.7      REST OF EUROPE             270

10.4         ASIA PACIFIC     278

10.4.1      MACROECONOMIC OUTLOOK  278

10.4.2      CHINA  289

10.4.2.1  Rapidly growing geriatric population to propel market  289

10.4.3      JAPAN   297

10.4.3.1  High adoption of advanced technologies to support market growth    297

10.4.4      INDIA    306

10.4.4.1  Rising prevalence of chronic diseases to drive market    306

10.4.5      AUSTRALIA         314

10.4.5.1  Increasing investments in research to provide opportunities for market growth       314

10.4.6      SOUTH KOREA  322

10.4.6.1  Presence of well-developed healthcare systems to propel market                 322

10.4.7      REST OF ASIA PACIFIC   330

10.5         LATIN AMERICA                338

10.5.1      MACROECONOMIC OUTLOOK  339

10.5.2      BRAZIL 347

10.5.2.1  Favourable demographic conditions to drive market      347

10.5.3      MEXICO                356

10.5.3.1  Increased medical tourism and better government healthcare initiatives to drive market   356

10.5.4      REST OF LATIN AMERICA             364

10.6         MIDDLE EAST & AFRICA                372

10.6.1      MACROECONOMIC OUTLOOK  372

10.6.2      GCC COUNTRIES              381

10.6.2.1  Expansion of healthcare providers to drive growth         381

10.6.3      REST OF MIDDLE EAST & AFRICA             389

11            COMPETITIVE LANDSCAPE         397

11.1         OVERVIEW          397

11.2         KEY PLAYER STRATEGIES/RIGHT TO WIN            397

11.2.1      OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN BIOPSY DEVICES MARKET      397

11.3         REVENUE ANALYSIS       399

11.4         MARKET SHARE ANALYSIS           399

11.5         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023                 402

11.5.1      STARS   402

11.5.2      EMERGING LEADERS     402

11.5.3      PERVASIVE PLAYERS      402

11.5.4      PARTICIPANTS 403

11.5.5      COMPANY FOOTPRINT: KEY PLAYERS, 2023         404

11.5.5.1  Company footprint               404

11.5.5.2  Region footprint   405

11.5.5.3  Product footprint  406

11.5.5.4  Technology footprint           407

11.5.5.5  Application footprint            408

11.5.5.6  End user footprint                 409

11.6         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023        410

11.6.1      PROGRESSIVE COMPANIES         410

11.6.2      RESPONSIVE COMPANIES            410

11.6.3      DYNAMIC COMPANIES  410

11.6.4      STARTING BLOCKS         410

11.6.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023                 411

11.7         COMPANY VALUATION & FINANCIAL METRICS 413

11.7.1      COMPANY VALUATION 413

11.7.2      FINANCIAL METRICS      413

11.8         BRAND/PRODUCT COMPARISON             414

11.9         COMPETITIVE SCENARIO             415

11.9.1      PRODUCT LAUNCHES & APPROVALS     415

11.9.2      DEALS  415

11.9.3      EXPANSIONS     416

12            COMPANY PROFILES      417

12.1         KEY PLAYERS     417

12.1.1      BD (BECTON, DICKINSON AND COMPANY)         417

12.1.1.1  Business overview 417

12.1.1.2  Products offered   419

12.1.1.3  Recent developments           427

12.1.1.3.1                Deals      427

12.1.1.4  MnM view              428

12.1.1.4.1                Key strengths        428

12.1.1.4.2                Strategic choices   428

12.1.1.4.3                Weaknesses & competitive threats     428

12.1.2      DEVICOR MEDICAL PRODUCTS, INC      429

12.1.2.1  Business overview 429

12.1.2.2  Products offered   430

12.1.2.3  Recent developments           433

12.1.2.3.1                Product launches & approvals            433

12.1.2.4  MnM view              433

12.1.2.4.1                Key strengths        433

12.1.2.4.2                Strategic choices   433

12.1.2.4.3                Weaknesses & competitive threats     434

12.1.3      MEDTRONIC      435

12.1.3.1  Business overview 435

12.1.3.2  Products offered   437

12.1.3.3  MnM view              438

12.1.3.3.1                Key strengths        438

12.1.3.3.2                Strategic choices   439

12.1.3.3.3                Weaknesses & competitive threats     439

12.1.4      CARDINAL HEALTH        440

12.1.4.1  Business overview 440

12.1.4.2  Products offered   442

12.1.4.3  MnM view              442

12.1.4.3.1                Key strengths        442

12.1.4.3.2                Strategic choices   442

12.1.4.3.3                Weaknesses & competitive threats     443

12.1.5      HOLOGIC, INC. 444

12.1.5.1  Business overview 444

12.1.5.2  Products offered   446

12.1.5.3  Recent developments           448

12.1.5.3.1                Deals      448

12.1.5.3.2                Other developments             449

12.1.5.4  MnM view              449

12.1.5.4.1                Key strengths        449

12.1.5.4.2                Strategic choices   449

12.1.5.4.3                Weaknesses & competitive threats     449

12.1.6      B. BRAUN SE       450

12.1.6.1  Business overview 450

12.1.6.2  Products offered   452

12.1.7      OLYMPUS CORPORATION           454

12.1.7.1  Business overview 454

12.1.7.2  Products offered   456

12.1.7.3  Recent developments           457

12.1.7.3.1                Deals      457

12.1.8      BOSTON SCIENTIFIC CORPORATION     458

12.1.8.1  Business overview 458

12.1.8.2  Products offered   460

12.1.9      FUJIFILM CORPORATION             462

12.1.9.1  Business overview 462

12.1.9.2  Products offered   464

12.1.10   STRYKER              465

12.1.10.1                 Business overview 465

12.1.10.2                 Products offered   466

12.1.11   TELEFLEX INCORPORATED        467

12.1.11.1                 Business overview 467

12.1.11.2                 Products offered   469

12.1.12   CONMED CORPORATION             470

12.1.12.1                 Business overview 470

12.1.12.2                 Products offered   472

12.1.13   MERIT MEDICAL SYSTEMS           474

12.1.13.1                 Business overview 474

12.1.13.2                 Products offered   476

12.1.14   JOHNSON & JOHNSON SERVICES, INC.   479

12.1.14.1                 Business overview 479

12.1.14.2                 Products offered   480

12.1.15   COOK GROUP   481

12.1.15.1                 Business overview 481

12.1.15.2                 Products offered   481

12.1.15.3                 Recent developments           484

12.1.15.3.1             Product launches & approvals            484

12.2         OTHER PLAYERS              485

12.2.1      MICROPORT SCIENTIFIC CORPORATION             485

12.2.2      ARGON MEDICAL DEVICES         486

12.2.3      INRAD, INC.        487

12.2.4      SUMMIT MEDICAL LLC 488

12.2.5      TRANSMED7, LLC             489

12.2.6      DR. JAPAN CO., LTD.       490

12.2.7      IZI MEDICAL PRODUCTS              491

12.2.8      PLANMED OY    492

12.2.9      ADVIN HEALTH CARE    493

12.2.10   TRIVITRON HEALTHCARE           494

13            APPENDIX           495

13.1         DISCUSSION GUIDE        495

13.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                500

13.3         CUSTOMIZATION OPTIONS        502

13.4         RELATED REPORTS         502

13.5         AUTHOR DETAILS           503

LIST OF TABLES

TABLE 1                BIOPSY DEVICES MARKET: INCLUSIONS & EXCLUSIONS      44

TABLE 2                STANDARD CURRENCY CONVERSION RATE, 2019–2024              45

TABLE 3                RESEARCH ASSUMPTIONS           57

TABLE 4                PORTER’S FIVE FORCES ANALYSIS           78

TABLE 5                BIOPSY DEVICES UNDER FDA’S REGULATION 21 CFR 876.1075       80

TABLE 6                NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  82

TABLE 7                EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  83

TABLE 8                ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  83

TABLE 9                LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  84

TABLE 10              MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  84

TABLE 11              LIST OF PATENTS IN BIOPSY DEVICES MARKET, 2014−2024            87

TABLE 12              IMPORT DATA FOR HS CODE 901831-COMPLIANT PRODUCTS, BY KEY COUNTRY, 2019–2023 (USD MILLION)            88

TABLE 13              EXPORT DATA FOR HS CODE 901831-COMPLIANT PRODUCTS, BY KEY COUNTRY, 2019–2023 (USD MILLION)            88

TABLE 14              AVERAGE SELLING PRICE OF KEY PLAYERS, BY KEY PRODUCT, 2021–2023 (USD)                89

TABLE 15              AVERAGE SELLING PRICE TREND OF BIOPSY DEVICES, BY REGION,

2021–2023 (USD)                90

TABLE 16              BIOPSY DEVICES MARKET: KEY CONFERENCES & EVENTS, 2025 90

TABLE 17              INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY END USERS  92

TABLE 18              KEY BUYING CRITERIA FOR KEY END USERS                 92

TABLE 19              BIOPSY DEVICES MARKET: UNMET NEEDS                 93

TABLE 20              BIOPSY DEVICES MARKET: EXPECTATIONS OF END USERS         93

TABLE 21              BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION)       104

TABLE 22              BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION)       104

TABLE 23              BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT,

2021–2023 (USD MILLION)            105

TABLE 24              BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT,

2024–2030 (USD MILLION)            105

TABLE 25              NEEDLE-BASED BIOPSY INSTRUMENT: BIOPSY DEVICES MARKET, BY COUNTRY/ REGION, 2021–2023 (USD MILLION)            106

TABLE 26              NEEDLE-BASED BIOPSY INSTRUMENT: BIOPSY DEVICES MARKET, BY COUNTRY/ REGION, 2024–2030 (USD MILLION)            107

TABLE 27              BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION)           108

TABLE 28              BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION)           108

TABLE 29              CORE NEEDLE BIOPSY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,

2021–2023 (USD MILLION)            109

TABLE 30              CORE NEEDLE BIOPSY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,

2024–2030 (USD MILLION)            110

TABLE 31              BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,

2021–2023 (USD MILLION)            111

TABLE 32              BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,

2024–2030 (USD MILLION)            111

TABLE 33              CORE NEEDLE BIOPSY DEVICE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION)            112

TABLE 34              CORE NEEDLE BIOPSY DEVICE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION)            113

TABLE 35              SEMI-AUTOMATIC: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,

2021–2023 (USD MILLION)            115

TABLE 36              SEMI-AUTOMATIC: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,

2024–2030 (USD MILLION)            116

TABLE 37              AUTOMATIC: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,

2021–2023 (USD MILLION)            117

TABLE 38              AUTOMATIC: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,

2024–2030 (USD MILLION)            118

TABLE 39              BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,

2021–2023 (USD MILLION)            119

TABLE 40              BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,

2024–2030 (USD MILLION)            119

TABLE 41              CORE NEEDLE BIOPSY NEEDLE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION)            120

TABLE 42              CORE NEEDLE BIOPSY NEEDLE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION)            121

TABLE 43              DISPOSABLE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,

2021–2023 (USD MILLION)            122

TABLE 44              DISPOSABLE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,

2024–2030 (USD MILLION)            123

TABLE 45              REUSABLE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,

2021–2023 (USD MILLION)            124

TABLE 46              REUSABLE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,

2024–2030 (USD MILLION)            125

TABLE 47              FINE NEEDLE ASPIRATION BIOPSY: BIOPSY DEVICES MARKET,

BY COUNTRY/REGION, 2021–2023 (USD MILLION)            126

TABLE 48              FINE NEEDLE ASPIRATION BIOPSY: BIOPSY DEVICES MARKET,

BY COUNTRY/REGION, 2024–2030 (USD MILLION)            127

TABLE 49              VACUUM-ASSISTED BIOPSY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION)                 129

TABLE 50              VACUUM-ASSISTED BIOPSY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION)                 130

TABLE 51              VISUALIZATION DEVICE/SYSTEM: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION)            132

TABLE 52              VISUALIZATION DEVICE/SYSTEM: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION)            133

TABLE 53              BRUSH BIOPSY INSTRUMENT: BIOPSY DEVICES MARKET, BY COUNTRY/ REGION, 2021–2023 (USD MILLION)                 134

TABLE 54              BRUSH BIOPSY INSTRUMENT: BIOPSY DEVICES MARKET, BY COUNTRY/ REGION, 2024–2030 (USD MILLION)                 135

TABLE 55              BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION) 136

TABLE 56              BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION) 136

TABLE 57              BIOPSY ACCESSORY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,

2021–2023 (USD MILLION)            137

TABLE 58              BIOPSY ACCESSORY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,

2024–2030 (USD MILLION)            138

TABLE 59              BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION)            139

TABLE 60              BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION)            139

TABLE 61              BIOPSY FORECEP: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,

2021–2023 (USD MILLION)            140

TABLE 62              BIOPSY FORECEP: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,

2024–2030 (USD MILLION)            141

TABLE 63              GENERAL BIOPSY FORECEP: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION)                 142

TABLE 64              GENERAL BIOPSY FORECEP: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION)                 143

TABLE 65              HOT BIOPSY FORECEP: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,

2021–2023 (USD MILLION)            144

TABLE 66              HOT BIOPSY FORECEP: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,

2024–2030 (USD MILLION)            145

TABLE 67              TISSUE MARKER: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,

2021–2023 (USD MILLION)            146

TABLE 68              TISSUE MARKER: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,

2024–2030 (USD MILLION)            147

TABLE 69              LOCALIZATION WIRE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,

2021–2023 (USD MILLION)            148

TABLE 70              LOCALIZATION WIRE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,

2024–2030 (USD MILLION)            149

TABLE 71              OTHER ACCESSORIES: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,

2021–2023 (USD MILLION)            150

TABLE 72              OTHER ACCESSORIES: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,

2024–2030 (USD MILLION)            151

TABLE 73              ROBOTIC BIOPSY DEVICE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION)                 152

TABLE 74              ROBOTIC BIOPSY DEVICE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION)                 153

TABLE 75              BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)            155

TABLE 76              BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION)            155

TABLE 77              ULTRASOUND-GUIDED BIOPSY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION)            156

TABLE 78              ULTRASOUND-GUIDED BIOPSY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION)            157

TABLE 79              STEREOTACTIC-GUIDED BIOPSY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION)            158

TABLE 80              STEREOTACTIC-GUIDED BIOPSY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION)            159

TABLE 81              OTHER TECHNOLOGIES: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,

2021–2023 (USD MILLION)            160

TABLE 82              OTHER TECHNOLOGIES: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,

2024–2030 (USD MILLION)            161

TABLE 83              BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)            163

TABLE 84              BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)            163

TABLE 85              ONCOLOGY: BIOPSY DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)                164

TABLE 86              ONCOLOGY: BIOPSY DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)                164

TABLE 87              ONCOLOGY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,

2021–2023 (USD MILLION)            165

TABLE 88              ONCOLOGY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,

2024–2030 (USD MILLION)            166

TABLE 89              BREAST CANCER: BIOPSY DEVICES CANCER MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION)                 167

TABLE 90              BREAST CANCER: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,

2024–2030 (USD MILLION)            168

TABLE 91              SOFT TISSUE CANCER: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,

2021–2023 (USD MILLION)            169

TABLE 92              SOFT TISSUE CANCER: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,

2024–2030 (USD MILLION)            170

TABLE 93              GASTROENTEROLOGY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,

2021–2023 (USD MILLION)            171

TABLE 94              GASTROENTEROLOGY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,

2024–2030 (USD MILLION)            172

TABLE 95              BONE & BONE MARROW: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,

2021–2023 (USD MILLION)            173

TABLE 96              BONE & BONE MARROW: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,

2024–2030 (USD MILLION)            174

TABLE 97              OTHER APPLICATIONS: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,

2021–2023 (USD MILLION)            175

TABLE 98              OTHER APPLICATIONS: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,

2024–2030 (USD MILLION)            176

TABLE 99              BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)       178

TABLE 100            BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)       178

TABLE 101            HOSPITALS & BREAST CARE CENTERS: BIOPSY DEVICES MARKET,

BY COUNTRY/REGION, 2021–2023 (USD MILLION)            180

TABLE 102            HOSPITALS & BREAST CARE CENTERS: BIOPSY DEVICES MARKET,

BY COUNTRY/REGION, 2024–2030 (USD MILLION)            181

TABLE 103            DIAGNOSTIC IMAGING CENTERS: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION)            183

TABLE 104            DIAGNOSTIC IMAGING CENTERS: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION)            184

TABLE 105            AMBULATORY SURGICAL CENTERS: BIOPSY DEVICES MARKET,

BY COUNTRY/REGION, 2021–2023 (USD MILLION)            185

TABLE 106            AMBULATORY SURGICAL CENTERS: BIOPSY DEVICES MARKET,

BY COUNTRY/REGION, 2024–2030 (USD MILLION)            186

TABLE 107            OTHER END USERS: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,

2021–2023 (USD MILLION)            187

TABLE 108            OTHER END USERS: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,

2024–2030 (USD MILLION)            188

TABLE 109            BIOPSY DEVICES MARKET, BY REGION, 2021–2023 (USD MILLION)       191

TABLE 110            BIOPSY DEVICES MARKET, BY REGION, 2024–2030 (USD MILLION)       192

TABLE 111            BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2030 (THOUSAND UNITS)             193

TABLE 112            NORTH AMERICA: BIOPSY DEVICES MARKET, BY COUNTRY,

2021–2023 (USD MILLION)            194

TABLE 113            NORTH AMERICA: BIOPSY DEVICES MARKET, BY COUNTRY,

2024–2030 (USD MILLION)            195

TABLE 114            NORTH AMERICA: BIOPSY DEVICES MARKET, BY PRODUCT,

2021–2023 (USD MILLION)            195

TABLE 115            NORTH AMERICA: BIOPSY DEVICES MARKET, BY PRODUCT,

2024–2030 (USD MILLION)            195

TABLE 116            NORTH AMERICA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION)            196

TABLE 117            NORTH AMERICA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION)            196

TABLE 118            NORTH AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,

2021–2023 (USD MILLION)            196

TABLE 119            NORTH AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,

2024–2030 (USD MILLION)            197

TABLE 120            NORTH AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION)                 197

TABLE 121            NORTH AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION)                 197

TABLE 122            NORTH AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION)                 198

TABLE 123            NORTH AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION)                 198

TABLE 124            NORTH AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,

2021–2023 (USD MILLION)            198

TABLE 125            NORTH AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,

2024–2030 (USD MILLION)            199

TABLE 126            NORTH AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,

2021–2023 (USD MILLION)            199

TABLE 127            NORTH AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,

2024–2030 (USD MILLION)            199

TABLE 128            NORTH AMERICA: BIOPSY DEVICES MARKET, BY TECHNOLOGY,

2021–2023 (USD MILLION)            200

TABLE 129            NORTH AMERICA: BIOPSY DEVICES MARKET, BY TECHNOLOGY,

2024–2030 (USD MILLION)            200

TABLE 130            NORTH AMERICA: BIOPSY DEVICES MARKET, BY APPLICATION,

2021–2023 (USD MILLION)            200

TABLE 131            NORTH AMERICA: BIOPSY DEVICES MARKET, BY APPLICATION,

2024–2030 (USD MILLION)            201

TABLE 132            NORTH AMERICA: BIOPSY DEVICES MARKET, BY ONCOLOGY,

2021–2023 (USD MILLION)            201

TABLE 133            NORTH AMERICA: BIOPSY DEVICES MARKET, BY ONCOLOGY,

2024–2030 (USD MILLION)            201

TABLE 134            NORTH AMERICA: BIOPSY DEVICES MARKET, BY END USER,

2021–2023 (USD MILLION)            202

TABLE 135            NORTH AMERICA: BIOPSY DEVICES MARKET, BY END USER,

2024–2030 (USD MILLION)            202

TABLE 136            NORTH AMERICA: BIOPSY DEVICES MARKET, BY PRODUCT,

2021–2030 (THOUSAND UNITS)  203

TABLE 137            US: MACRO-INDICATORS IMPACTING MARKET                 204

TABLE 138            US: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION)            204

TABLE 139            US: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION)            205

TABLE 140            US: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT,

2021–2023 (USD MILLION)            205

TABLE 141            US: BIOPSY DEVICES MARKET, BY NEEDLE BASED BIOPSY INSTRUMENT,

2024–2030 (USD MILLION)            205

TABLE 142            US: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,

2021–2023 (USD MILLION)            206

TABLE 143            US: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,

2024–2030 (USD MILLION)            206

TABLE 144            US: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,

2021–2023 (USD MILLION)            206

TABLE 145            US: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,

2024–2030 (USD MILLION)            207

TABLE 146            US: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,

2021–2023 (USD MILLION)            207

TABLE 147            US: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,

2024–2030 (USD MILLION)            207

TABLE 148            US: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,

2021–2023 (USD MILLION)            208

TABLE 149            US: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,

2024–2030 (USD MILLION)            208

TABLE 150            US: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION)       208

TABLE 151            US: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION)       209

TABLE 152            US: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)            209

TABLE 153            US: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION)            209

TABLE 154          US: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)            210

TABLE 155          US: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)            210

TABLE 156            US: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION)            210

TABLE 157            US: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION)            211

TABLE 158            US: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)            211

TABLE 159            US: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)            211

TABLE 160            CANADA: MACRO-INDICATORS IMPACTING MARKET               212

TABLE 161            CANADA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION)     212

TABLE 162            CANADA: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION)     213

TABLE 163            CANADA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION)            213

TABLE 164            CANADA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION)            213

TABLE 165            CANADA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,

2021–2023 (USD MILLION)            214

TABLE 166            CANADA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,

2024–2030 (USD MILLION)            214

TABLE 167            CANADA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,

2021–2023 (USD MILLION)            214

TABLE 168            CANADA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,

2024–2030 (USD MILLION)            215

TABLE 169            CANADA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,

2021–2023 (USD MILLION)            215

TABLE 170            CANADA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,

2024–2030 (USD MILLION)            215

TABLE 171            CANADA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,

2021–2023 (USD MILLION)            216

TABLE 172            CANADA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,

2024–2030 (USD MILLION)            216

TABLE 173            CANADA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,

2021–2023 (USD MILLION)            216

TABLE 174            CANADA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,

2024–2030 (USD MILLION)            217

TABLE 175            CANADA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)            217

TABLE 176            CANADA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION)            217

TABLE 177            CANADA: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)              218

TABLE 178            CANADA: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)              218

TABLE 179            CANADA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION) 218

TABLE 180            CANADA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION) 219

TABLE 181            CANADA: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)                219

TABLE 182            CANADA: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)                219

TABLE 183            EUROPE: BIOPSY DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)     220

TABLE 184            EUROPE: BIOPSY DEVICES MARKET, BY COUNTRY, 2024–2030 (USD MILLION)     221

TABLE 185            EUROPE: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION)     221

TABLE 186            EUROPE: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION)     222

TABLE 187            EUROPE: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION)            222

TABLE 188            EUROPE: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION)            222

TABLE 189            EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,

2021–2023 (USD MILLION)            223

TABLE 190            EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,

2024–2030 (USD MILLION)            223

TABLE 191            EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,

2021–2023 (USD MILLION)            223

TABLE 192            EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,

2024–2030 (USD MILLION)            224

TABLE 193            EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,

2021–2023 (USD MILLION)            224

TABLE 194            EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,

2024–2030 (USD MILLION)            224

TABLE 195            EUROPE: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,

2021–2023 (USD MILLION)            225

TABLE 196            EUROPE: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,

2024–2030 (USD MILLION)            225

TABLE 197            EUROPE: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,

2021–2023 (USD MILLION)            225

TABLE 198            EUROPE: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,

2024–2030 (USD MILLION)            226

TABLE 199            EUROPE: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)            226

TABLE 200            EUROPE: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION)            226

TABLE 201            EUROPE: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)              227

TABLE 202            EUROPE: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)              227

TABLE 203            EUROPE: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION) 227

TABLE 204            EUROPE: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION) 228

TABLE 205            EUROPE: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)                228

TABLE 206            EUROPE: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)                228

TABLE 207            EUROPE: BIOPSY DEVICES MARKET, BY PRODUCT,

2021–2030 (THOUSAND UNITS)  229

TABLE 208            GERMANY: MACRO-INDICATORS IMPACTING MARKET               230

TABLE 209            GERMANY: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION)     230

TABLE 210            GERMANY: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION)     230

TABLE 211            GERMANY: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION)            231

TABLE 212            GERMANY: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION)            231

TABLE 213            GERMANY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,

2021–2023 (USD MILLION)            231

TABLE 214            GERMANY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,

2024–2030 (USD MILLION)            232

TABLE 215            GERMANY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,

2021–2023 (USD MILLION)            232

TABLE 216            GERMANY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,

2024–2030 (USD MILLION)            232

TABLE 217            GERMANY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,

2021–2023 (USD MILLION)            233

TABLE 218            GERMANY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,

2024–2030 (USD MILLION)            233

TABLE 219            GERMANY: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,

2021–2023 (USD MILLION)            233

TABLE 220            GERMANY: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,

2024–2030 (USD MILLION)            234

TABLE 221            GERMANY: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,

2021–2023 (USD MILLION)            234

TABLE 222            GERMANY: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,

2024–2030 (USD MILLION)            234

TABLE 223            GERMANY: BIOPSY DEVICES MARKET, BY TECHNOLOGY,

2021–2023 (USD MILLION)            235

TABLE 224            GERMANY: BIOPSY DEVICES MARKET, BY TECHNOLOGY,

2024–2030 (USD MILLION)            235

TABLE 225            GERMANY: BIOPSY DEVICES MARKET, BY APPLICATION,

2021–2023 (USD MILLION)            235

TABLE 226            GERMANY: BIOPSY DEVICES MARKET, BY APPLICATION,

2024–2030 (USD MILLION)            236

TABLE 227            GERMANY: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION) 236

TABLE 228            GERMANY: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION) 236

TABLE 229            GERMANY: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)                237

TABLE 230            GERMANY: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)                237

TABLE 231            UK: MACRO-INDICATORS IMPACTING MARKET                 238

TABLE 232            UK: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION)            238

TABLE 233            UK: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION)            238

TABLE 234            UK: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT,

2021–2023 (USD MILLION)            239

TABLE 235            UK: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT,

2024–2030 (USD MILLION)            239

TABLE 236            UK: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,

2021–2023 (USD MILLION)            239

TABLE 237            UK: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,

2024–2030 (USD MILLION)            240

TABLE 238            UK: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,

2021–2023 (USD MILLION)            240

TABLE 239            UK: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,

2024–2030 (USD MILLION)            240

TABLE 240            UK: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,

2021–2023 (USD MILLION)            241

TABLE 241            UK: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,

2024–2030 (USD MILLION)            241

TABLE 242            UK: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,

2021–2023 (USD MILLION)            241

TABLE 243            UK: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,

2024–2030 (USD MILLION)            242

TABLE 244            UK: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION)       242

TABLE 245            UK: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION)       242

TABLE 246            UK: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)            243

TABLE 247            UK: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION)            243

TABLE 248            UK: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)              243

TABLE 249            UK: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)              244

TABLE 250            UK: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION)            244

TABLE 251            UK: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION)            244

TABLE 252            UK: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)            245

TABLE 253            UK: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)            245

TABLE 254            FRANCE: MACRO-INDICATORS IMPACTING GROWTH             246

TABLE 255            FRANCE: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION)     246

TABLE 256            FRANCE: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION)     247

TABLE 257            FRANCE: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION)            247

TABLE 258            FRANCE: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION)            247

TABLE 259            FRANCE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,

2021–2023 (USD MILLION)            248

TABLE 260            FRANCE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,

2024–2030 (USD MILLION)            248

TABLE 261            FRANCE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,

2021–2023 (USD MILLION)            248

TABLE 262            FRANCE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,

2024–2030 (USD MILLION)            249

TABLE 263            FRANCE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,

2021–2023 (USD MILLION)            249

TABLE 264            FRANCE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,

2024–2030 (USD MILLION)            249

TABLE 265            FRANCE: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,

2021–2023 (USD MILLION)            250

TABLE 266            FRANCE: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,

2024–2030 (USD MILLION)            250

TABLE 267            FRANCE: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,

2021–2023 (USD MILLION)            250

TABLE 268            FRANCE: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,

2024–2030 (USD MILLION)            251

TABLE 269            FRANCE: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)            251

TABLE 270            FRANCE: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION)            251

TABLE 271            FRANCE: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)              252

TABLE 272            FRANCE: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)              252

TABLE 273            FRANCE: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION) 252

TABLE 274            FRANCE: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION) 253

TABLE 275            FRANCE: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)                253

TABLE 276            FRANCE: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)                253

TABLE 277            ITALY: MACRO-INDICATORS IMPACTING MARKET               254

TABLE 278            ITALY: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION)            254

TABLE 279            ITALY: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION)            255

TABLE 280            ITALY: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT,

2021–2023 (USD MILLION)            255

TABLE 281            ITALY: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT,

2024–2030 (USD MILLION)            255

TABLE 282            ITALY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,

2021–2023 (USD MILLION)            256

TABLE 283            ITALY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,

2024–2030 (USD MILLION)          256

TABLE 284            ITALY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,

2021–2023 (USD MILLION)            256

TABLE 285            ITALY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,

2024–2030 (USD MILLION)            257

TABLE 286            ITALY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,

2021–2023 (USD MILLION)            257

TABLE 287            ITALY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,

2024–2030 (USD MILLION)            257

TABLE 288            ITALY: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,

2021–2023 (USD MILLION)            258

TABLE 289            ITALY: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,

2024–2030 (USD MILLION)            258

TABLE 290            ITALY: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,

2021–2023 (USD MILLION)            258

TABLE 291            ITALY: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,

2024–2030 (USD MILLION)            259

TABLE 292            ITALY: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)            259

TABLE 293            ITALY: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION)            259

TABLE 294            ITALY: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)              260

TABLE 295            ITALY: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)              260

TABLE 296            ITALY: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION) 260

TABLE 297            ITALY: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION) 261

TABLE 298            ITALY: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)            261

TABLE 299            ITALY: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)            261

TABLE 300            SPAIN: MACRO-INDICATORS IMPACTING MARKET               262

TABLE 301            SPAIN: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION)            262

TABLE 302            SPAIN: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION)            263

TABLE 303            SPAIN: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION)                 263

TABLE 304            SPAIN: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION)                 263

TABLE 305            SPAIN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,

2021–2023 (USD MILLION)            264

TABLE 306            SPAIN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,

2024–2030 (USD MILLION)            264

TABLE 307            SPAIN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,

2021–2023 (USD MILLION)            264

TABLE 308            SPAIN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,

2024–2030 (USD MILLION)            265

TABLE 309            SPAIN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,

2021–2023 (USD MILLION)            265

TABLE 310            SPAIN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,

2024–2030 (USD MILLION)          265

TABLE 311            SPAIN: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,

2021–2023 (USD MILLION)            266

TABLE 312            SPAIN: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,

2024–2030 (USD MILLION)            266

TABLE 313            SPAIN: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,

2021–2023 (USD MILLION)            266

TABLE 314            SPAIN: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,

2024–2030 (USD MILLION)            267

TABLE 315            SPAIN: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)            267

TABLE 316            SPAIN: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION)            267

TABLE 317            SPAIN: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)              268

TABLE 318            SPAIN: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)              268

TABLE 319            SPAIN: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION) 268

TABLE 320            SPAIN: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION) 269

TABLE 321            SPAIN: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)            269

TABLE 322            SPAIN: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)            269

TABLE 323            REST OF EUROPE: BIOPSY DEVICES MARKET, BY PRODUCT,

2021–2023 (USD MILLION)            270

TABLE 324            REST OF EUROPE: BIOPSY DEVICES MARKET, BY PRODUCT,

2024–2030 (USD MILLION)            271

TABLE 325            REST OF EUROPE: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION)            271

TABLE 326            REST OF EUROPE: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION)            271

TABLE 327            REST OF EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,

2021–2023 (USD MILLION)            272

TABLE 328            REST OF EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,

2024–2030 (USD MILLION)            272

TABLE 329            REST OF EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION)                 272

TABLE 330            REST OF EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION)                 273

TABLE 331            REST OF EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION)                 273

TABLE 332            REST OF EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION)                 273

TABLE 333            REST OF EUROPE: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,

2021–2023 (USD MILLION)            274

TABLE 334            REST OF EUROPE: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,

2024–2030 (USD MILLION)            274

TABLE 335            REST OF EUROPE: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,

2021–2023 (USD MILLION)            274

TABLE 336            REST OF EUROPE: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,

2024–2030 (USD MILLION)            275

TABLE 337            REST OF EUROPE: BIOPSY DEVICES MARKET, BY TECHNOLOGY,

2021–2023 (USD MILLION)            275

TABLE 338            REST OF EUROPE: BIOPSY DEVICES MARKET, BY TECHNOLOGY,

2024–2030 (USD MILLION)            275

TABLE 339            REST OF EUROPE: BIOPSY DEVICES MARKET, BY APPLICATION,

2021–2023 (USD MILLION)            276

TABLE 340            REST OF EUROPE: BIOPSY DEVICES MARKET, BY APPLICATION,

2024–2030 (USD MILLION)            276

TABLE 341            REST OF EUROPE: BIOPSY DEVICES MARKET, BY ONCOLOGY,

2021–2023 (USD MILLION)            276

TABLE 342            REST OF EUROPE: BIOPSY DEVICES MARKET, BY ONCOLOGY,

2024–2030 (USD MILLION)            277

TABLE 343            REST OF EUROPE: BIOPSY DEVICES MARKET, BY END USER,

2021–2023 (USD MILLION)            277

TABLE 344            REST OF EUROPE: BIOPSY DEVICES MARKET, BY END USER,

2024–2030 (USD MILLION)            277

TABLE 345            ASIA PACIFIC: BIOPSY DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)     280

TABLE 346            ASIA PACIFIC: BIOPSY DEVICES MARKET, BY COUNTRY, 2024–2030 (USD MILLION)     280

TABLE 347            ASIA PACIFIC: BIOPSY DEVICES MARKET, BY PRODUCT,

2021–2023 (USD MILLION)            281

TABLE 348            ASIA PACIFIC: BIOPSY DEVICES MARKET, BY PRODUCT,

2024–2030 (USD MILLION)            281

TABLE 349            ASIA PACIFIC: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION)            282

TABLE 350            ASIA PACIFIC: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION)            282

TABLE 351            ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,

2021–2023 (USD MILLION)            282

TABLE 352            ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,

2024–2030 (USD MILLION)            283

TABLE 353            ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,

2021–2023 (USD MILLION)            283

TABLE 354            ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,

2024–2030 (USD MILLION)            283

TABLE 355            ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION)                 284

TABLE 356            ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION)                 284

TABLE 357            ASIA PACIFIC: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,

2021–2023 (USD MILLION)            284

TABLE 358            ASIA PACIFIC: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,

2024–2030 (USD MILLION)            285

TABLE 359            ASIA PACIFIC: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,

2021–2023 (USD MILLION)            285

TABLE 360            ASIA PACIFIC: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,

2024–2030 (USD MILLION)            285

TABLE 361            ASIA PACIFIC: BIOPSY DEVICES MARKET, BY TECHNOLOGY,

2021–2023 (USD MILLION)            286

TABLE 362            ASIA PACIFIC: BIOPSY DEVICES MARKET, BY TECHNOLOGY,

2024–2030 (USD MILLION)            286

TABLE 363            ASIA PACIFIC: BIOPSY DEVICES MARKET, BY APPLICATION,

2021–2023 (USD MILLION)            286

TABLE 364            ASIA PACIFIC: BIOPSY DEVICES MARKET, BY APPLICATION,

2024–2030 (USD MILLION)            287

TABLE 365            ASIA PACIFIC: BIOPSY DEVICES MARKET, BY ONCOLOGY,

2021–2023 (USD MILLION)            287

TABLE 366            ASIA PACIFIC: BIOPSY DEVICES MARKET, BY ONCOLOGY,

2024–2030 (USD MILLION)          287

TABLE 367            ASIA PACIFIC: BIOPSY DEVICES MARKET, BY END USER,

2021–2023 (USD MILLION)            288

TABLE 368            ASIA PACIFIC: BIOPSY DEVICES MARKET, BY END USER,

2024–2030 (USD MILLION)            288

TABLE 369            ASIA PACIFIC: BIOPSY DEVICES MARKET, BY PRODUCT,

2021–2030 (THOUSAND UNITS)  289

TABLE 370            CHINA: MACRO-INDICATORS IMPACTING MARKET               290

TABLE 371          CHINA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION)            290

TABLE 372          CHINA: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION)            290

TABLE 373            CHINA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION)                 291

TABLE 374            CHINA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION)                 291

TABLE 375            CHINA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,

2021–2023 (USD MILLION)            291

TABLE 376            CHINA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,

2024–2030 (USD MILLION)            292

TABLE 377            CHINA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,

2021–2023 (USD MILLION)            292

TABLE 378            CHINA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,

2024–2030 (USD MILLION)            292

TABLE 379            CHINA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,

2021–2023 (USD MILLION)            293

TABLE 380            CHINA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,

2024–2030 (USD MILLION)            293

TABLE 381            CHINA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,

2021–2023 (USD MILLION)            293

TABLE 382            CHINA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,

2024–2030 (USD MILLION)            294

TABLE 383            CHINA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,

2021–2023 (USD MILLION)            294

TABLE 384            CHINA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,

2024–2030 (USD MILLION)            294

TABLE 385            CHINA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)            295

TABLE 386            CHINA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION)            295

TABLE 387            CHINA: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)              295

TABLE 388            CHINA: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)              296

TABLE 389            CHINA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION) 296

TABLE 390            CHINA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION) 296

TABLE 391          CHINA: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)            297

TABLE 392          CHINA: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)            297

TABLE 393            JAPAN: MACRO-INDICATORS IMPACTING MARKET               298

TABLE 394          JAPAN: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION)            298

TABLE 395          JAPAN: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION)            299

TABLE 396            JAPAN: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION)                 299

TABLE 397            JAPAN: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION)                 299

TABLE 398            JAPAN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,

2021–2023 (USD MILLION)            300

TABLE 399            JAPAN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,

2024–2030 (USD MILLION)            300

TABLE 400            JAPAN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,

2021–2023 (USD MILLION)            300

TABLE 401            JAPAN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,

2024–2030 (USD MILLION)            301

TABLE 402            JAPAN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,

2021–2023 (USD MILLION)            301

TABLE 403            JAPAN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,

2024–2030 (USD MILLION)            301

TABLE 404            JAPAN: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,

2021–2023 (USD MILLION)            302

TABLE 405            JAPAN: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,

2024–2030 (USD MILLION)            302

TABLE 406            JAPAN: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,

2021–2023 (USD MILLION)            302

TABLE 407            JAPAN: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,

2024–2030 (USD MILLION)            303

TABLE 408            JAPAN: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)            303

TABLE 409            JAPAN: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION)            304

TABLE 410            JAPAN: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)              304

TABLE 411            JAPAN: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)              305

TABLE 412            JAPAN: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION) 305

TABLE 413            JAPAN: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION) 305

TABLE 414            JAPAN: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)            306

TABLE 415            JAPAN: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)            306

TABLE 416            INDIA: MACRO-INDICATORS IMPACTING GROWTH             307

TABLE 417            INDIA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION)            307

TABLE 418            INDIA: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION)            307

TABLE 419            INDIA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT,

2021–2023 (USD MILLION)            308

TABLE 420            INDIA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT,

2024–2030 (USD MILLION)            308

TABLE 421            INDIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,

2021–2023 (USD MILLION)            308

TABLE 422            INDIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,

2024–2030 (USD MILLION)            309

TABLE 423            INDIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,

2021–2023 (USD MILLION)            309

TABLE 424            INDIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,

2024–2030 (USD MILLION)            309

TABLE 425            INDIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,

2021–2023 (USD MILLION)            310

TABLE 426            INDIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,

2024–2030 (USD MILLION)            310

TABLE 427            INDIA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,

2021–2023 (USD MILLION)            310

TABLE 428            INDIA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,

2024–2030 (USD MILLION)            311

TABLE 429            INDIA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,

2021–2023 (USD MILLION)            311

TABLE 430            INDIA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,

2024–2030 (USD MILLION)            311

TABLE 431            INDIA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)            312

TABLE 432            INDIA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION)            312

TABLE 433            INDIA: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)              312

TABLE 434            INDIA: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)              313

TABLE 435            INDIA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION) 313

TABLE 436            INDIA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION) 313

TABLE 437            INDIA: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)            314

TABLE 438            INDIA: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)            314

TABLE 439            AUSTRALIA: MACRO-INDICATORS IMPACTING MARKET               315

TABLE 440            AUSTRALIA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION)     315

TABLE 441            AUSTRALIA: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION)     315

TABLE 442            AUSTRALIA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION)            316

TABLE 443            AUSTRALIA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION)            316

TABLE 444            AUSTRALIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,

2021–2023 (USD MILLION)            316

TABLE 445            AUSTRALIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,

2024–2030 (USD MILLION)            317

TABLE 446            AUSTRALIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,

2021–2023 (USD MILLION)            317

TABLE 447            AUSTRALIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,

2024–2030 (USD MILLION)            317

TABLE 448            AUSTRALIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,

2021–2023 (USD MILLION)            318

TABLE 449            AUSTRALIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,

2024–2030 (USD MILLION)            318

TABLE 450            AUSTRALIA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,

2021–2023 (USD MILLION)            318

TABLE 451            AUSTRALIA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,

2024–2030 (USD MILLION)            319

TABLE 452            AUSTRALIA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,

2021–2023 (USD MILLION)            319

TABLE 453            AUSTRALIA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,

2024–2030 (USD MILLION)            319

TABLE 454            AUSTRALIA: BIOPSY DEVICES MARKET, BY TECHNOLOGY,

2021–2023 (USD MILLION)            320

TABLE 455            AUSTRALIA: BIOPSY DEVICES MARKET, BY TECHNOLOGY,

2024–2030 (USD MILLION)            320

TABLE 456            AUSTRALIA: BIOPSY DEVICES MARKET, BY APPLICATION,

2021–2023 (USD MILLION)            320

TABLE 457            AUSTRALIA: BIOPSY DEVICES MARKET, BY APPLICATION,

2024–2030 (USD MILLION)            321

TABLE 458            AUSTRALIA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION) 321

TABLE 459            AUSTRALIA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION) 321

TABLE 460            AUSTRALIA: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)                322

TABLE 461            AUSTRALIA: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)                322

TABLE 462            SOUTH KOREA: MACRO-INDICATORS IMPACTING MARKET     323

TABLE 463            SOUTH KOREA: BIOPSY DEVICES MARKET, BY PRODUCT,

2021–2023 (USD MILLION)            323

TABLE 464            SOUTH KOREA: BIOPSY DEVICES MARKET, BY PRODUCT,

2024–2030 (USD MILLION)            323

TABLE 465            SOUTH KOREA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION)            324

TABLE 466            SOUTH KOREA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION)            324

TABLE 467            SOUTH KOREA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,

2021–2023 (USD MILLION)            324

TABLE 468            SOUTH KOREA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,

2024–2030 (USD MILLION)            325

TABLE 469            SOUTH KOREA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION)                 325

TABLE 470            SOUTH KOREA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION)                 325

TABLE 471            SOUTH KOREA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION)                 326

TABLE 472            SOUTH KOREA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION)                 326

TABLE 473            SOUTH KOREA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,

2021–2023 (USD MILLION)            326

TABLE 474            SOUTH KOREA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,

2024–2030 (USD MILLION)            327

TABLE 475            SOUTH KOREA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,

2021–2023 (USD MILLION)            327

TABLE 476            SOUTH KOREA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,

2024–2030 (USD MILLION)            327

TABLE 477            SOUTH KOREA: BIOPSY DEVICES MARKET, BY TECHNOLOGY,

2021–2023 (USD MILLION)            328

TABLE 478            SOUTH KOREA: BIOPSY DEVICES MARKET, BY TECHNOLOGY,

2024–2030 (USD MILLION)            328

TABLE 479            SOUTH KOREA: BIOPSY DEVICES MARKET, BY APPLICATION,

2021–2023 (USD MILLION)            328

TABLE 480            SOUTH KOREA: BIOPSY DEVICES MARKET, BY APPLICATION,

2024–2030 (USD MILLION)            329

TABLE 481            SOUTH KOREA: BIOPSY DEVICES MARKET, BY ONCOLOGY,

2021–2023 (USD MILLION)            329

TABLE 482            SOUTH KOREA: BIOPSY DEVICES MARKET, BY ONCOLOGY,

2024–2030 (USD MILLION)            329

TABLE 483            SOUTH KOREA: BIOPSY DEVICES MARKET, BY END USER,

2021–2023 (USD MILLION)            330

TABLE 484            SOUTH KOREA: BIOPSY DEVICES MARKET, BY END USER,

2024–2030 (USD MILLION)            330

TABLE 485            REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY PRODUCT,

2021–2023 (USD MILLION)            331

TABLE 486            REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY PRODUCT,

2024–2030 (USD MILLION)            331

TABLE 487            REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION) 332

TABLE 488            REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION) 332

TABLE 489            REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION)                 332

TABLE 490            REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION)                 333

TABLE 491            REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION)            333

TABLE 492            REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION)            333

TABLE 493            REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION)            334

TABLE 494            REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION)            334

TABLE 495            REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,

2021–2023 (USD MILLION)            334

TABLE 496            REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,

2024–2030 (USD MILLION)            335

TABLE 497            REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,

2021–2023 (USD MILLION)            335

TABLE 498            REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,

2024–2030 (USD MILLION)            335

TABLE 499            REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY TECHNOLOGY,

2021–2023 (USD MILLION)            336

TABLE 500            REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY TECHNOLOGY,

2024–2030 (USD MILLION)            336

TABLE 501            REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY APPLICATION,

2021–2023 (USD MILLION)            336

TABLE 502            REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY APPLICATION,

2024–2030 (USD MILLION)            337

TABLE 503            REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY ONCOLOGY,

2021–2023 (USD MILLION)            337

TABLE 504            REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY ONCOLOGY,

2024–2030 (USD MILLION)            337

TABLE 505            REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY END USER,

2021–2023 (USD MILLION)            338

TABLE 506            REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY END USER,

2024–2030 (USD MILLION)            338

TABLE 507            LATIN AMERICA: BIOPSY DEVICES MARKET, BY COUNTRY,

2021–2023 (USD MILLION)            339

TABLE 508            LATIN AMERICA: BIOPSY DEVICES MARKET, BY COUNTRY,

2024–2030 (USD MILLION)            339

TABLE 509            LATIN AMERICA: BIOPSY DEVICES MARKET, BY PRODUCT,

2021–2023 (USD MILLION)            340

TABLE 510            LATIN AMERICA: BIOPSY DEVICES MARKET, BY PRODUCT,

2024–2030 (USD MILLION)            340

TABLE 511            LATIN AMERICA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION)            340

TABLE 512            LATIN AMERICA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION)            341

TABLE 513            LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,

2021–2023 (USD MILLION)            341

TABLE 514            LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,

2024–2030 (USD MILLION)            341

TABLE 515            LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION)                 342

TABLE 516            LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION)                 342

TABLE 517            LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION)                 342

TABLE 518            LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION)                 343

TABLE 519            LATIN AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,

2021–2023 (USD MILLION)            343

TABLE 520            LATIN AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,

2024–2030 (USD MILLION)            343

TABLE 521            LATIN AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,

2021–2023 (USD MILLION)            344

TABLE 522            LATIN AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,

2024–2030 (USD MILLION)            344

TABLE 523            LATIN AMERICA: BIOPSY DEVICES MARKET, BY TECHNOLOGY,

2021–2023 (USD MILLION)            344

TABLE 524            LATIN AMERICA: BIOPSY DEVICES MARKET, BY TECHNOLOGY,

2024–2030 (USD MILLION)            345

TABLE 525            LATIN AMERICA: BIOPSY DEVICES MARKET, BY APPLICATION,

2021–2023 (USD MILLION)            345

TABLE 526            LATIN AMERICA: BIOPSY DEVICES MARKET, BY APPLICATION,

2024–2030 (USD MILLION)            345

TABLE 527            LATIN AMERICA: BIOPSY DEVICES MARKET, BY ONCOLOGY,

2021–2023 (USD MILLION)            346

TABLE 528            LATIN AMERICA: BIOPSY DEVICES MARKET, BY ONCOLOGY,

2024–2030 (USD MILLION)            346

TABLE 529            LATIN AMERICA: BIOPSY DEVICES MARKET, BY END USER,

2021–2023 (USD MILLION)            346

TABLE 530            LATIN AMERICA: BIOPSY DEVICES MARKET, BY END USER,

2024–2030 (USD MILLION)            347

TABLE 531            LATIN AMERICA: BIOPSY DEVICES MARKET, BY PRODUCT,

2021–2030 (THOUSAND UNITS)  347

TABLE 532            BRAZIL: MACRO-INDICATORS IMPACTING MARKET               348

TABLE 533            BRAZIL: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION)     348

TABLE 534            BRAZIL: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION)     349

TABLE 535            BRAZIL: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION)                 349

TABLE 536            BRAZIL: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION)                 349

TABLE 537            BRAZIL: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,

2021–2023 (USD MILLION)            350

TABLE 538            BRAZIL: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,

2024–2030 (USD MILLION)            350

TABLE 539            BRAZIL: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,

2021–2023 (USD MILLION)            350

TABLE 540            BRAZIL: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,

2024–2030 (USD MILLION)            351

TABLE 541            BRAZIL: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,

2021–2023 (USD MILLION)            351

TABLE 542            BRAZIL: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,

2024–2030 (USD MILLION)            351

TABLE 543            BRAZIL: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,

2021–2023 (USD MILLION)            352

TABLE 544            BRAZIL: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,

2024–2030 (USD MILLION)            352

TABLE 545            BRAZIL: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,

2021–2023 (USD MILLION)            352

TABLE 546            BRAZIL: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,

2024–2030 (USD MILLION)            353

TABLE 547            BRAZIL: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)            353

TABLE 548            BRAZIL: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION)            353

TABLE 549            BRAZIL: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)              354

TABLE 550            BRAZIL: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)              354

TABLE 551            BRAZIL: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION) 354

TABLE 552            BRAZIL: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION) 355

TABLE 553            BRAZIL: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)                355

TABLE 554            BRAZIL: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)                355

TABLE 555            MEXICO: MACRO-INDICATORS IMPACTING MARKET               356

TABLE 556            MEXICO: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION)     357

TABLE 557            MEXICO: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION)     357

TABLE 558            MEXICO: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION)            357

TABLE 559            MEXICO: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION)            358

TABLE 560            MEXICO: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,

2021–2023 (USD MILLION)            358

TABLE 561            MEXICO: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,

2024–2030 (USD MILLION)            358

TABLE 562            MEXICO: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,

2021–2023 (USD MILLION)            359

TABLE 563            MEXICO: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,

2024–2030 (USD MILLION)            359

TABLE 564            MEXICO: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,

2021–2023 (USD MILLION)            359

TABLE 565            MEXICO: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,

2024–2030 (USD MILLION)            360

TABLE 566            MEXICO: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,

2021–2023 (USD MILLION)            360

TABLE 567            MEXICO: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,

2024–2030 (USD MILLION)            360

TABLE 568            MEXICO: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,

2021–2023 (USD MILLION)            361

TABLE 569            MEXICO: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,

2024–2030 (USD MILLION)            361

TABLE 570            MEXICO: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)            361

TABLE 571            MEXICO: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION)            362

TABLE 572            MEXICO: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)              362

TABLE 573            MEXICO: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)              362

TABLE 574            MEXICO: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION) 363

TABLE 575            MEXICO: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION) 363

TABLE 576            MEXICO: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)                363

TABLE 577            MEXICO: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)                364

TABLE 578            REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY PRODUCT,

2021–2023 (USD MILLION)            364

TABLE 579            REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY PRODUCT,

2024–2030 (USD MILLION)            365

TABLE 580            REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION) 365

TABLE 581            REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION) 365

TABLE 582            REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION)                 366

TABLE 583            REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION)                 366

TABLE 584            REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION)            366

TABLE 585            REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION)            367

TABLE 586            REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION)            367

TABLE 587            REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION)            367

TABLE 588            REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION)                 368

TABLE 589            REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION)                 368

TABLE 590            REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,

2021–2023 (USD MILLION)            368

TABLE 591            REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,

2024–2030 (USD MILLION)            369

TABLE 592            REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY TECHNOLOGY,

2021–2023 (USD MILLION)            369

TABLE 593            REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY TECHNOLOGY,

2024–2030 (USD MILLION)            369

TABLE 594            REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY APPLICATION,

2021–2023 (USD MILLION)            370

TABLE 595            REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY APPLICATION,

2024–2030 (USD MILLION)            370

TABLE 596            REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY ONCOLOGY,

2021–2023 (USD MILLION)            370

TABLE 597            REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY ONCOLOGY,

2024–2030 (USD MILLION)            371

TABLE 598            REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY END USER,

2021–2023 (USD MILLION)            371

TABLE 599            REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY END USER,

2024–2030 (USD MILLION)            371

TABLE 600            MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY COUNTRY,

2021–2023 (USD MILLION)            372

TABLE 601            MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY COUNTRY,

2024–2030 (USD MILLION)            372

TABLE 602            MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY PRODUCT,

2021–2023 (USD MILLION)            373

TABLE 603            MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY PRODUCT,

2024–2030 (USD MILLION)            373

TABLE 604            MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION) 374

TABLE 605            MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION) 374

TABLE 606            MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION)                 374

TABLE 607            MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION)                 375

TABLE 608            MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION)            375

TABLE 609            MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION)            375

TABLE 610            MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION)            376

TABLE 611            MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION)            376

TABLE 612            MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION)                 376

TABLE 613            MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION)                 377

TABLE 614            MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,

2021–2023 (USD MILLION)            377

TABLE 615            MIDDLE EAST &AFRICA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,

2024–2030 (USD MILLION)            377

TABLE 616            MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY TECHNOLOGY,

2021–2023 (USD MILLION)            378

TABLE 617            MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY TECHNOLOGY,

2024–2030 (USD MILLION)            378

TABLE 618            MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY APPLICATION,

2021–2023 (USD MILLION)            378

TABLE 619            MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY APPLICATION,

2024–2030 (USD MILLION)            379

TABLE 620            MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY ONCOLOGY,

2021–2023 (USD MILLION)            379

TABLE 621            MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY ONCOLOGY,

2024–2030 (USD MILLION)            379

TABLE 622            MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY END USER,

2021–2023 (USD MILLION)            380

TABLE 623            MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY END USER,

2024–2030 (USD MILLION)            380

TABLE 624            MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY PRODUCT,

2021–2030 (THOUSAND UNITS)  381

TABLE 625            GCC COUNTRIES: BIOPSY DEVICES MARKET, BY PRODUCT,

2021–2023 (USD MILLION)            382

TABLE 626            GCC COUNTRIES: BIOPSY DEVICES MARKET, BY PRODUCT,

2024–2030 (USD MILLION)            382

TABLE 627            GCC COUNTRIES: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION)            382

TABLE 628            GCC COUNTRIES: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION)            383

TABLE 629            GCC COUNTRIES: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,

2021–2023 (USD MILLION)            383

TABLE 630            GCC COUNTRIES: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,

2024–2030 (USD MILLION)            383

TABLE 631            GCC COUNTRIES: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION)                 384

TABLE 632            GCC COUNTRIES: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION)                 384

TABLE 633            GCC COUNTRIES: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION)                 384

TABLE 634            GCC COUNTRIES: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION)                 385

TABLE 635            GCC COUNTRIES: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,

2021–2023 (USD MILLION)            385

TABLE 636            GCC COUNTRIES: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,

2024–2030 (USD MILLION)            385

TABLE 637            GCC COUNTRIES: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,

2021–2023 (USD MILLION)            386

TABLE 638            GCC COUNTRIES: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,

2024–2030 (USD MILLION)            386

TABLE 639            GCC COUNTRIES: BIOPSY DEVICES MARKET, BY TECHNOLOGY,

2021–2023 (USD MILLION)            386

TABLE 640            GCC COUNTRIES: BIOPSY DEVICES MARKET, BY TECHNOLOGY,

2024–2030 (USD MILLION)            387

TABLE 641            GCC COUNTRIES: BIOPSY DEVICES MARKET, BY APPLICATION,

2021–2023 (USD MILLION)            387

TABLE 642            GCC COUNTRIES: BIOPSY DEVICES MARKET, BY APPLICATION,

2024–2030 (USD MILLION)            387

TABLE 643            GCC COUNTRIES: BIOPSY DEVICES MARKET, BY ONCOLOGY,

2021–2023 (USD MILLION)            388

TABLE 644            GCC COUNTRIES: BIOPSY DEVICES MARKET, BY ONCOLOGY,

2024–2030 (USD MILLION)            388

TABLE 645            GCC COUNTRIES: BIOPSY DEVICES MARKET, BY END USER,

2021–2023 (USD MILLION)            388

TABLE 646            GCC COUNTRIES: BIOPSY DEVICES MARKET, BY END USER,

2024–2030 (USD MILLION)            389

TABLE 647            REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY PRODUCT,

2021–2023 (USD MILLION)            389

TABLE 648            REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY PRODUCT,

2024–2030 (USD MILLION)            390

TABLE 649            REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION)            390

TABLE 650            REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION)            390

TABLE 651            REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION)            391

TABLE 652            REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION)            391

TABLE 653            REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION) 391

TABLE 654            REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION) 392

TABLE 655            REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION) 392

TABLE 656            REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION) 392

TABLE 657            REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION)            393

TABLE 658            REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION)            393

TABLE 659            REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION)            393

TABLE 660            REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION)            394

TABLE 661            REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)                 394

TABLE 662            REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION)                 394

TABLE 663            REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)                 395

TABLE 664            REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)                 395

TABLE 665            REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION)                 395

TABLE 666            REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION)                 396

TABLE 667            REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY END USER,

2021–2023 (USD MILLION)            396

TABLE 668            REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY END USER,

2024–2030 (USD MILLION)            396

TABLE 669            OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN BIOPSY DEVICES MARKET  397

TABLE 670            BIOPSY DEVICES MARKET: DEGREE OF COMPETITION 400

TABLE 671            BIOPSY DEVICES MARKET: REGION FOOTPRINT                 405

TABLE 672            BIOPSY DEVICES MARKET: PRODUCT FOOTPRINT       406

TABLE 673            BIOPSY DEVICES MARKET: TECHNOLOGY FOOTPRINT       407

TABLE 674            BIOPSY DEVICES MARKET: APPLICATION FOOTPRINT       408

TABLE 675            BIOPSY DEVICES MARKET: END USER FOOTPRINT       409

TABLE 676            BIOPSY DEVICES MARKET: DETAILED LIST OF KEY STARTUPS/SMES    411

TABLE 677            BIOPSY DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY REGION                412

TABLE 678            BIOPSY DEVICES MARKET: PRODUCT LAUNCHES & APPROVALS,

JANUARY 2021–JANUARY 2025     415

TABLE 679            BIOPSY DEVICES MARKET: DEALS, JANUARY 2021–JANUARY 2025         415

TABLE 680            BIOPSY DEVICES MARKET: EXPANSIONS, JANUARY 2021–JANUARY 2025     416

TABLE 681            BD (BECTON, DICKINSON AND COMPANY): COMPANY OVERVIEW   417

TABLE 682            BD (BECTON, DICKINSON AND COMPANY): PRODUCTS OFFERED    419

TABLE 683            BD (BECTON, DICKINSON AND COMPANY): DEALS, JANUARY 2021–JANUARY 2025      427

TABLE 684            DEVICOR MEDICAL PRODUCTS, INC: COMPANY OVERVIEW          429

TABLE 685            DEVICOR MEDICAL PRODUCTS, INC: PRODUCTS OFFERED    430

TABLE 686            DEVICOR MEDICAL PRODUCTS, INC: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025                 433

TABLE 687            MEDTRONIC: COMPANY OVERVIEW       435

TABLE 688            MEDTRONIC: PRODUCTS OFFERED        437

TABLE 689            CARDINAL HEALTH: COMPANY OVERVIEW                 440

TABLE 690            CARDINAL HEALTH: PRODUCTS OFFERED                 442

TABLE 691            HOLOGIC, INC.: COMPANY OVERVIEW  444

TABLE 692            HOLOGIC, INC: PRODUCTS OFFERED    446

TABLE 693            HOLOGIC, INC: DEALS, JANUARY 2021–JANUARY 2025        448

TABLE 694            B. BRAUN SE: COMPANY OVERVIEW       450

TABLE 695            B. BRAUN SE: PRODUCTS OFFERED        452

TABLE 696            OLYMPUS CORPORATION: COMPANY OVERVIEW          454

TABLE 697            OLYMPUS CORPORATION: PRODUCTS OFFERED             456

TABLE 698            OLYMPUS CORPORATION: DEALS, JANUARY 2021–JANUARY 2025         457

TABLE 699            BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW   458

TABLE 700            BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED    460

TABLE 701            FUJIFILM CORPORATION: COMPANY OVERVIEW          462

TABLE 702            FUJIFILM CORPORATION: PRODUCTS OFFERED                 464

TABLE 703            STRYKER: COMPANY OVERVIEW               465

TABLE 704            STRYKER: PRODUCTS OFFERED                466

TABLE 705            TELEFLEX INCORPORATED: COMPANY OVERVIEW          467

TABLE 706            TELEFLEX INCORPORATED: PRODUCTS OFFERED             469

TABLE 707            CONMED CORPORATION: COMPANY OVERVIEW          470

TABLE 708            CONMED CORPORATION: PRODUCTS OFFERED             472

TABLE 709            MERIT MEDICAL SYSTEMS: COMPANY OVERVIEW          474

TABLE 710            MERIT MEDICAL SYSTEMS: PRODUCTS OFFERED             476

TABLE 711            MERIT MEDICAL SYSTEMS: PRODUCT LAUNCHES & APPROVALS,

JANUARY 2021–JANUARY 2025     478

TABLE 712            MERIT MEDICAL SYSTEMS: DEALS, JANUARY 2021–JANUARY 2025         478

TABLE 713            JOHNSON & JOHNSON SERVICES, INC.: COMPANY OVERVIEW   479

TABLE 714            JOHNSON & JOHNSON SERVICES INC.: PRODUCTS OFFERED    480

TABLE 715            COOK GROUP: COMPANY OVERVIEW    481

TABLE 716            COOK GROUP: PRODUCTS OFFERED     481

TABLE 717            COOK GROUP: PRODUCT LAUNCHES & APPROVALS,

JANUARY 2021–JANUARY 2025     484

LIST OF FIGURES

FIGURE 1              RESEARCH DESIGN         47

FIGURE 2              PRIMARY SOURCES         50

FIGURE 3              BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,

DESIGNATION, AND REGION     52

FIGURE 4              MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS            53

FIGURE 5              TOP-DOWN APPROACH                53

FIGURE 6              IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES     55

FIGURE 7              BIOPSY DEVICES MARKET: CAGR PROJECTIONS                 55

FIGURE 8              DATA TRIANGULATION METHODOLOGY                 57

FIGURE 9              BIOPSY DEVICES MARKET, BY PRODUCT, 2024 VS. 2030 (USD MILLION)                59

FIGURE 10            BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT,

2024 VS. 2030 (USD MILLION)      60

FIGURE 11            BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,

2024 VS. 2030 (USD MILLION)      60

FIGURE 12            BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024 VS. 2030 (USD MILLION)      61

FIGURE 13            BIOPSY DEVICES MARKET, BY APPLICATION, 2024 VS. 2030 (USD MILLION)      61

FIGURE 14            BIOPSY DEVICES MARKET, BY END USER, 2024 VS. 2030 (USD MILLION)                62

FIGURE 15            NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARE IN 2023 63

FIGURE 16            RISING CASES OF CANCER TO DRIVE GLOBAL ADOPTION OF BIOPSY DEVICES               64

FIGURE 17            US AND HOSPITALS & BREAST CARE CENTERS SEGMENT ACCOUNTED FOR SIGNIFICANT SHARE IN 2023                 65

FIGURE 18            CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD       66

FIGURE 19            ASIA PACIFIC TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD       67

FIGURE 20            DEVELOPING MARKET SEGMENT TO REGISTER HIGHER GROWTH THAN DEVELOPED MARKET SEGMENT BY 2030        67

FIGURE 21            BIOPSY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES         68

FIGURE 22            TRENDS IN BIOPSY DEVICES MARKET    73

FIGURE 23            BIOPSY DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS           79

FIGURE 24            NUMBER OF PATENTS PUBLISHED, 2014–2025                 85

FIGURE 25            TOP TEN PATENT OWNERS FOR BIOPSY DEVICES, 2014−2025        86

FIGURE 26            TOP APPLICANTS FOR BIOPSY DEVICES, 2014−2025            86

FIGURE 27            AVERAGE SELLING PRICE OF KEY PLAYERS, BY KEY PRODUCT, 2021–2023 (USD)                89

FIGURE 28            AVERAGE SELLING PRICE TREND OF BIOPSY DEVICES, BY REGION,

2021–2023 (USD)                90

FIGURE 29            INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY END USERS  91

FIGURE 30            KEY BUYING CRITERIA FOR KEY END USERS                 92

FIGURE 31            BIOPSY DEVICES MARKET: ECOSYSTEM ANALYSIS            94

FIGURE 32            BIOPSY DEVICES MARKET: SUPPLY CHAIN ANALYSIS            98

FIGURE 33            REVENUE SHIFT FOR BIOPSY DEVICES MARKET                 100

FIGURE 34            INVESTMENT & FUNDING SCENARIO, 2019–2023 (USD MILLION) 101

FIGURE 35            USE OF AI/GEN AI IN BIOPSY PROCEDURES                 102

FIGURE 36            NORTH AMERICA: BIOPSY DEVICES MARKET SNAPSHOT          194

FIGURE 37            ASIA PACIFIC: BIOPSY DEVICES MARKET SNAPSHOT          279

FIGURE 38            REVENUE ANALYSIS OF KEY PLAYERS, 2021–2023 (USD MILLION) 399

FIGURE 39            MARKET SHARE ANALYSIS, 2023                 400

FIGURE 40            RANKING OF KEY PLAYERS IN BIOPSY DEVICES MARKET, 2023    402

FIGURE 41            BIOPSY DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023         403

FIGURE 42            BIOPSY DEVICES MARKET: COMPANY FOOTPRINT       404

FIGURE 43            BIOPSY DEVICES MARKET: COMPANY EVALUATION MATRIX

(STARTUPS/SMES), 2023                411

FIGURE 44            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK

BETA OF KEY VENDORS                413

FIGURE 45            EV/EBITDA OF KEY PLAYERS      413

FIGURE 46            BIOPSY DEVICES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS            414

FIGURE 47            BD (BECTON, DICKINSON AND COMPANY): COMPANY SNAPSHOT (2024)      418

FIGURE 48            DEVICOR MEDICAL PRODUCTS, INC: COMPANY SNAPSHOT (2023)             430

FIGURE 49            MEDTRONIC: COMPANY SNAPSHOT (2024)                 436

FIGURE 50            CARDINAL HEALTH: COMPANY SNAPSHOT (2024)    441

FIGURE 51            HOLOGIC, INC.: COMPANY SNAPSHOT (2024)                 445

FIGURE 52            B. BRAUN SE: COMPANY SNAPSHOT (2023)                 451

FIGURE 53            OLYMPUS CORPORATION: COMPANY SNAPSHOT (2024)             455

FIGURE 54            BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2023)      459

FIGURE 55            FUJIFILM CORPORATION: COMPANY SNAPSHOT (2024)             463

FIGURE 56            STRYKER: COMPANY SNAPSHOT (2023) 466

FIGURE 57            TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2023)             468

FIGURE 58            CONMED CORPORATION: COMPANY SNAPSHOT (2023)             471

FIGURE 59            MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT (2023)             475

FIGURE 60            JOHNSON & JOHNSON SERVICES, INC.: COMPANY SNAPSHOT (2023)      480

MarketsandMarkets（マーケッツアンドマーケッツ）は広範な市場を対象にした市場調査レポートを出版しています。世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• UV安定剤市場 – 2030年までの世界予測 2025-05-16
• 産業用通信市場 – 2030年までの世界予測 2025-05-16
• 経腸栄養装置市場 – 2030年までの世界予測 2025-05-15
• データセンターGPU市場 – 2030年までの世界予測 2025-05-15
• ステンレス鋼シームレスパイプ市場 – 2030年までの世界予測 2025-05-15

MarketsandMarkets  出版レポート一覧